HealthStrat Consulting

HealthStrat is specialized in business intelligence
and strategy in life sciences both
pharmaceuticals and medical devices.

The founder, Emilie Hofstetter, has deep domain knowledge in cardiovascular and respiratory diseases paired with an extensive network of KOLs. She is regularly attending scientific meetings and has active scientific society memberships.

Engage together for value creation

based on superior insight, positioning and implementation

ABOUT

Strategic insight rooted in science and industry
experience.

Profound expertise combined with solid approach
  • More than 20-year experience in life sciences industry, and consulting
  • Translating science into business with focus on respiratory and cardiac disease
  • Both in pharmaceuticals and medical devices, particularly heart failure and structural heart diseases including valvular diseases
  • Pharmaceutical company founder, investor, and board member
  • Several clients with successful exit:
    - Breath Therapeutics GmbH with lung transplantation drug and inhaled delivery,
    - Xenios AG with mechanical support for heart and lung diseases,
    - Activareo GmbH with asthma drugs and inhaled delivery,
    - Vessis Medical Inc. with a device for renal denervation
  • Evaluate your business opportunity and market barriers, including market access
  • Assess your competitive landscape, with a both 360° perspective integrating pharmaceuticals and medical devices
  • Develop solid analytics and actionable insight to define your market potentials, patient funnels, and build forecasting models
  • Implement insight into your business planning and strategy
  • Build solid foundation for development with expertise and dedication
  • Enable your opportunity to sustained value growth
OUR SERVICES

Delivering analytical
depth and practical
solutions for value growth.

Opportunity assessment

  • Patient segmentation
  • Disease specific parameters
  • Market size and growth
  • Peak sales calculation

Insight generation for strategy development

  • Secondary research
  • Prepare and coordinate primary
    research in cooperation with partners

Competitive and business landscape analysis

  • We access direct and indirect competition as well as trends
  • We integrate both pharmaceuticals and medical devices, their strengthens and weaknesses

Business and strategic planning early stage and along the clinical journey

  • Business and strategic planning is an iterative process that evolves with clinical phases and results
  • We grow actionable insight along this journey and translate it into the planning processe

Due Diligence Activities

  • We support our clients through due diligence, backing their business and strategic plan
  • We conduct commercial and market access due diligence for venture capital and medtech companies

Growing value for partnering and exit preparation

  • We articulate the value of your opportunity for fund raising, partnering, and exit

CLIENTS - PARTNERS

Partnering with companies and investors shaping the future of healthcare.

Clients
  • Start-ups early and mid-stage along the clinical journey both in pharmaceuticals and medical device
  • Large medtech corporations assessing new opportunities
  • Venture capital companies
Partners
  • Partner for market access in Europe
  • Partner for clinical development
PUBLICATIONS AND SPEAKER

  • Co-authored “Life Science Venturing” - Gabler Verlag 2017
  • Gaede L et al. Trends in aortic valve replacement in Germany in 2015. Clin Res Cardiol. 2017;106(6)411-419 – Data generation
  • Gaede L et al. Outcome after transvascular transcatheter aortic valve implantation in 2016. European Heart Journal. 2018 Feb21;39(8):667-675 – Data generation
  • Kemp R et al. Relationship between FEV1 decline and mortality in patients with bronchiolitis obliterans syndrome - a systematic literature review. Respir Med, Nov. 2021
  • Eleven posters/abstracts on Trends and burden in Lung and Allogeneic Stem Cell Transplantation, as well as Bronchiolitis Obliterans Syndrome. ACT Annual Meeting 2024 - ASH Annual Meeting 2019 - ATS Annual Meeting 2024 - Chest Annual Meeting Nov 2022 - EBMT Annual Meeting March 2020 - ERS Annual Meeting 2019, 2024 - ISHLT Annual Meeting 2021, 2022, 2024 – ISPOR Europe Nov. 2019
     
  • Speaker at conferences and meetings: ERS Annual Meeting Sept. 2019, Chest Annual Meeting Oct. 2022, ISHLT April 2024